As on October 25, 2021, T2 Biosystems Inc. (NASDAQ: TTOO) started slowly as it slid -0.73% to $0.87 before settling in for the price of $0.88 at the close. Taking a more long-term approach, TTOO posted a 52-week range of $0.81-$3.79.
It was noted that the giant of the Healthcare sector posted annual sales growth of 45.20% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 29.50%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 70.30%. This publicly-traded company’s shares outstanding now amounts to $154.88 million, simultaneously with a float of $142.75 million. The organization now has a market capitalization sitting at $136.07 million. At the time of writing, stock’s 50-day Moving Average stood at $0.9172, while the 200-day Moving Average is $1.4133.
It is quite fundamental to gauge the extent of the productivity of the business which is accounted for 148 workers. It has generated 122,500 per worker during the last fiscal year. Meanwhile, its income per employee was -316,203. The stock had 4.58 Receivables turnover and 0.34 Total Asset turnover. For the Profitability, stocks gross margin was -13.87, operating margin was -221.72 and Pretax Margin of -258.12.
T2 Biosystems Inc. (TTOO) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Diagnostics & Research industry. T2 Biosystems Inc.’s current insider ownership accounts for 0.60%, in contrast to 16.90% institutional ownership. According to the most recent insider trade that took place on Jul 01, this organization’s Director sold 18,182 shares at the rate of 1.16, making the entire transaction reach 21,091 in total value, affecting insider ownership by 516,386. Preceding that transaction, on Mar 25, Company’s General Counsel sold 8,758 for 1.56, making the whole transaction’s value amount to 13,662. This particular insider is now the holder of 73,256 in total.
T2 Biosystems Inc. (TTOO) Earnings and Revenue Records
If we go through the results of last quarter, which was made public on 6/29/2021, the company posted -$0.08 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$0.08) by $0. This company achieved a net margin of -258.12. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.08 per share during the current fiscal year.
T2 Biosystems Inc.’s EPS increase for this current 12-month fiscal period is 70.30% and is forecasted to reach -0.30 in the upcoming year.
T2 Biosystems Inc. (NASDAQ: TTOO) Trading Performance Indicators
Let’s observe the current performance indicators for T2 Biosystems Inc. (TTOO). It’s Quick Ratio in the last reported quarter now stands at 6.30. The Stock has managed to achieve an average true range (ATR) of 0.05. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 5.10.
In the same vein, TTOO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.29, a figure that is expected to reach -0.08 in the next quarter, and analysts are predicting that it will be -0.30 at the market close of one year from today.
Technical Analysis of T2 Biosystems Inc. (TTOO)
Through scrutinizing the latest numbers posted by the [T2 Biosystems Inc., TTOO], it can be observed that its last 5-days Average volume of 4.62 million was lower the volume of 6.6 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 34.34% While, its Average True Range was 0.0504.
Raw Stochastic average of T2 Biosystems Inc. (TTOO) in the period of the previous 100 days is set at 9.25%, which indicates a major fall in contrast to 41.33% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 40.53% that was lower than 67.54% volatility it exhibited in the past 100-days period.